Osteoporosis Disease Management Demonstration Project

This study has been completed.
Sponsor:
Information provided by:
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00145067
First received: September 1, 2005
Last updated: October 25, 2009
Last verified: October 2009
  Purpose

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.


Condition Intervention
Osteoporosis
Behavioral: Disease Management Assessment

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis

Resource links provided by NLM:


Further study details as provided by Merck Sharp & Dohme Corp.:

Primary Outcome Measures:
  • Treatment persistence

Secondary Outcome Measures:
  • Patient satisfaction and knowledge

Estimated Enrollment: 230
Study Start Date: November 2003
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion Criteria:

  • Individuals who are not members of the Kaiser Permanente Health Plan.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00145067

Sponsors and Collaborators
Merck Sharp & Dohme Corp.
Investigators
Study Director: Medical Monitor Merck Sharp & Dohme Corp.
  More Information

No publications provided by Merck Sharp & Dohme Corp.

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Executive Vice President, Clinical and Quantitative Sciences, Merck & Co., Inc.
ClinicalTrials.gov Identifier: NCT00145067     History of Changes
Other Study ID Numbers: 2005_051, 040
Study First Received: September 1, 2005
Last Updated: October 25, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on April 16, 2014